期刊文献+

脂联素的生物学作用及临床应用 被引量:5

Biological functions and clinical implications of adiponectin
下载PDF
导出
摘要 脂联素(adiponectin,APN)是一种脂肪细胞为主分泌的细胞因子,已证实其具有调节代谢、血管内皮保护、抗炎症反应及心肌细胞保护等多种生物学作用,并发现其也可作为潜在的心血管疾病的生物学标志物。本文根据基础医学、转化医学研究的结果及临床流行病学数据,综述了APN的生物学作用及其临床应用前景。 Adiponectin is one of the key adipokines. Identified biological functions of adiponectin include metabolic regulation, vascular protection, anti-inflammation and eardioproteetive actions. Numerous clinical studies have demonstrated that adiponeetin is one potential biological marker of cardiovascular diseases. In the present review, the biological functions and clinical prospect of adiponectin are discussed based on the findings of basic science and translational medicine along with clinical epidemiological data.
出处 《心脏杂志》 CAS 2013年第1期90-92,共3页 Chinese Heart Journal
基金 国家自然科学基金青年项目资助(81100137)
关键词 脂联素 脂肪细胞 生物学作用 临床应用 adiponectin adipokines cardioprotection metabolism bio-marker
  • 相关文献

参考文献12

  • 1樊荣,臧益民.脂肪组织的功与过评述[J].心脏杂志,2008,20(3):370-371. 被引量:5
  • 2Davis KE, Scherer PE. Adiponectin : no longer the lone soul in the fight against insulin resistance? [J]. Biochem J, 2008, 416(2) : e7 - e9.
  • 3Dcnzel MS, Scimia MC, Zumstein PM, et al. T-cadherin is critical for adiponectin-mediated cardioprotection in mice[ J]. J Clin Invest, 2010, 120(12) :4342 -4352.
  • 4Halberg N, Schraw TD, Wang ZV, et al. Systemic fate of the adipo- cyte-derived factor adiponectin [ J ]. Diabetes, 2009, 58 ( 9 ) : 1961 - 1670.
  • 5Brown JE, Conner AC, Digby JE, et al. Regulation of betacell via- bility and gene expression by distinct agonist fragments of adiponec- tin [ J ]. Peptides, 2010, 31 ( 5 ) :944 - 949.
  • 6Holland WL, Miller RA, Wang ZV, et al. Receptor-mediated acti- vation of ceramidase activity initiates the pleiotropic actions of adi- ponectin[ J]. Nat Med, 2011, 17( 1 ) :55 -63.
  • 7Sharma K, Ramachandrarao S, Qiu G, et al. Adiponectin regulates albuminuria and podocyte function in mice [ J ]. J Clin Invest, 2008, 118(5) :1645 - 1656.
  • 8Lo MM, Salisbury S, Scherer PE, et al. Serum adiponectin comple- xes and cardiovascular risk in children with chronic kidney disease [J]. Pediatr Nephrol, 2011, 26(11) :2009 -2017.
  • 9Yamauchi T, Nio Y, Maki T, et al. Targeted disruption of AdipoRl and AdipoR2 causes abrogation of adiponectin binding and metabolic actions[J].Nat Med, 2007, 13(3) :332 -339.
  • 10Polyzos SA, Toulis KA, Goulis DG, et al. Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta- analysis [ J ]. Metabolism, 2011, 60 ( 3 ) : 313 - 326.

二级参考文献11

共引文献4

同被引文献88

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部